CRISPR/Cas12-Based Ultra-Sensitive and Specific Point-of-Care Detection of HBV

CRISPR/Cas12-Based Ultra-Sensitive and Specific Point-of-Care Detection of HBV

Hepatitis B remains a major global public health challenge, with particularly high prevalence in medically disadvantaged western Pacific and African regions. Although clinically available technologies for the qPCR detection of HBV are well established, research on point-of-care testing has not progr...

Full description

Bibliographic Details
Main Authors: Ronghua Ding, Jinzhao Long, Mingzhu Yuan, Xue Zheng, Yue Shen, Yuefei Jin, Haiyan Yang, Hao Li, Shuaiyin Chen, Guangcai Duan
Format: Article
Language:English
Published: MDPI AG 2021-05-01
Series:International Journal of Molecular Sciences
Subjects:
Hepatitis B virus (HBV)
CRISPR/Cas12a
LAMP
point-of-care detection
Online Access:https://www.mdpi.com/1422-0067/22/9/4842

Internet

https://www.mdpi.com/1422-0067/22/9/4842

Similar Items